CMS certification 410007
Rhode Island Hospital
593 Eddy Street, Providence, RI 02902
Rhode Island Hospital has a CMS overall rating of 4 out of 5 stars. 69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 24 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on 2. Emergency patients spend a median of 4 h 18 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 393 completed surveys, 21% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | RI | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 360 visits sampled · US median for EDs of the same volume: 3 h 21 min | 4 h 18 min | 3 h 43 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 36 visits sampled | 5 h 11 min | 5 h 16 min | 4 h 17 min |
| Left before being seen Lower is better · 148,895 patients | 6% | 4% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 17 patients | 59% | 62% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 260 patients | 64% | 64% | 65% |
How Rhode Island Hospital compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Rhode Island HospitalThis hospital | 4/5 | 69% | 4 h 18 min | 3 better 2 worse |
| Women & Infants Hospital of Rhode IslandSame city | 4/5 | 71% | 3 h 54 min | 1 better |
| The Miriam HospitalSame city | 4/5 | 72% | 4 h 54 min | 6 better |
| Providence VA Medical CenterSame city | 4/5 | 78% | — | 2 worse |
| Roger Williams Medical CenterSame city | 3/5 | 60% | 3 h 32 min | 2 better |
| Our Lady of Fatima HospitalSame county · North Providence | 3/5 | 69% | 3 h 13 min | 1 better |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Providence.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 6,549 cases | Too few cases | 3.3% | 3.9% |
| Heart attack 239 cases | Too few cases | 12.7% | 11.9% |
| Heart failure 480 cases | Too few cases | 13.6% | 11.1% |
| Pneumonia 417 cases | Too few cases | 15.5% | 15.2% |
| Stroke 1,163 cases | Too few cases | 12.7% | 11.9% |
| COPD 123 cases | Too few cases | 9.3% | 8.6% |
| Heart bypass surgery (CABG) 113 cases | Too few cases | 2.5% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.75 likely 0.51 – 1 | 1 |
| Deaths after a serious but treatable surgical complication 192 cases | No different | 153.66 per 1,000 likely 116.56 per 1,000 – 190.76 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 9,667 cases | No different | 0.29 per 1,000 likely 0 per 1,000 – 0.78 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 11,050 cases | No different | 0.16 per 1,000 likely 0 per 1,000 – 0.33 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 11,091 cases | No different | 0.33 per 1,000 likely 0.15 per 1,000 – 0.5 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 3,158 cases | No different | 1.47 per 1,000 likely 0.26 per 1,000 – 2.69 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,346 cases | No different | 1.07 per 1,000 likely 0 per 1,000 – 2.45 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,300 cases | No different | 7.41 per 1,000 likely 2.6 per 1,000 – 12.23 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 3,480 cases | No different | 3.14 per 1,000 likely 1.55 per 1,000 – 4.72 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,362 cases | No different | 4.26 per 1,000 likely 1.11 per 1,000 – 7.42 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 568 cases | No different | 1.77 per 1,000 likely 0.37 per 1,000 – 3.18 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,928 cases | No different | 0.92 per 1,000 likely 0.02 per 1,000 – 1.82 per 1,000 | 1.06 per 1,000 |
1 more measure had too few cases here to report.
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.76 likely 0.5 – 1.11 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.52 likely 0.33 – 0.77 | 1 |
| Surgical site infections after colon surgery | No different | 0.85 likely 0.31 – 1.88 | 1 |
| MRSA bloodstream infections | No different | 0.69 likely 0.41 – 1.08 | 1 |
| C. diff intestinal infections | Better | 0.32 likely 0.23 – 0.44 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 495 cases | Too few cases | 15.8% | 14.4% |
| Readmitted after heart failure 1,148 cases | Too few cases | 19.9% | 21.3% |
| Readmitted after pneumonia 954 cases | Too few cases | 15.9% | 17.3% |
| Readmitted after COPD 426 cases | Too few cases | 19.5% | 20% |
| Readmitted after heart bypass surgery 143 cases | Too few cases | 9.5% | 11% |
| Days back in hospital after a heart attack 300 cases | Too few cases | 3.9 days per 100 | — |
| Days back in hospital after heart failure 561 cases | Too few cases | 19.6 days per 100 | — |
| Days back in hospital after pneumonia 437 cases | Too few cases | 10.6 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 696 cases | No different | 12.5 per 1,000 likely 9.5 per 1,000 – 16.4 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 847 cases | Better | 9 per 100 likely 7.6 per 100 – 10.6 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 847 cases | No different | 4.7 per 100 likely 3.8 per 100 – 5.8 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 573 cases | No different | 1 likely 0.7 – 1.3 | — |
2 more measures had too few cases here to report.
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $7.7M
- 2020 $10.7M
- 2021 $8.9M
- 2022 $6.4M
- 2023 $10.1M
- 2024 $8.5M
- 2025 $12.9M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $63,500 | 9 |
| Medical devices and supplies on long-term loan | $37,254 | 11 |
| Space rental and facility fees | $27,000 | 13 |
| Speaking, teaching and other services | $2,000 | 1 |
| Education | $2,000 | 1 |
| Royalties and licensing fees | $219 | 1 |
| Debt forgiveness | $90 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Daiichi Sankyo Inc. | $2.7M | 1,650 |
| AstraZeneca Pharmaceuticals LP | $2.1M | 17 |
| Genentech, Inc. | $1.5M | 101 |
| Abbvie INC. | $1.1M | 235 |
| Merck Sharp & Dohme LLC | $731,988 | 9 |
| Sanofi US Services INC. | $647,466 | 39 |
| Pfizer INC. | $643,730 | 65 |
| Novartis Pharmaceuticals Corporation | $527,542 | 7 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| DS3939-077 Daiichi Sankyo Inc. · NCT05875168 | $2.4M |
| A Randomized 2-cohort Double-blind Placebo-controlled Phase III Study of AZD5305 in Combination with Physicians Choice New Hormonal Agents in Patient… AstraZeneca Pharmaceuticals LP | $547,428 |
| A Phase 1/2, Open Label, First-in-human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and An… SANOFI US SERVICES INC. · NCT05584670 | $465,507 |
| BrUOG 401 a phase 2 study of mosunetuzumab with lenalidomide augmentation as first line therapy fo Genentech, Inc. | $444,028 |
| A Phase 1 First-in-Human Study Evaluating Safety, Pharmacokinetics, and Efficacy of ABBV-969 in Adult Subjects With Metastatic Castration-Resistant P… ABBVIE INC. · NCT06318273 | $395,320 |
| Phase 2 Study of Autogene Cevumeran in Adjuvant PDAC Genentech, Inc. | $369,871 |
| A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept versus Placebo for the Treatment of Combined Pos… Merck Sharp & Dohme LLC | $366,622 |
| Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenou… ABBVIE INC. · NCT06084481 | $354,511 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Rhode Island Hospital
Is Rhode Island Hospital a good hospital?
Rhode Island Hospital has a CMS overall rating of 4 out of 5 stars. Of the 24 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on 2. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Rhode Island Hospital?
69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 393 completed HCAHPS surveys.
How long is the wait in the Rhode Island Hospital emergency room?
Emergency patients spend a median of 4 h 18 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 6% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Rhode Island Hospital receive money from drug and device companies?
Drug and device makers reported $12.9M in payments to Rhode Island Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.